Personalized, or precision, medicine in type 2 diabetes mellitus is becoming a reality with new insights into the contributions of subgroup analyses. The roadmap to future implementation must take into account individual and subgroup variability in genetic architecture, environment, clinical measures, lifestyle, cost-effectiveness and treatment burden.

中文翻译：

---

利用 2 型糖尿病的异质性。

随着对亚组分析的贡献有了新的认识，2 型糖尿病的个性化或精准医疗正在成为现实。未来实施的路线图必须考虑到遗传结构、环境、临床措施、生活方式、成本效益和治疗负担方面的个体和亚组变异性。